Prediction markets could hit a trillion dollars in trading volume by the end of this decade, new report says

Prediction markets could hit a trillion dollars in trading volume by the end of this decade, new report says


Polymarket banner outside the New York Stock Exchange on Oct. 7th, 2025.

Kevin Stankiewicz | CNBC

Prediction markets could reach a trillion dollars in annual trading volume by the end of this decade, according to a new report from Eilers & Krejcik, a research firm that specializes in sports and interactive gaming sectors.  

“Numerous factors, most notably legal and regulatory challenges, could delay or derail the growth of prediction markets,” Eilers & Krejcik partner emeritus and strategic advisor Chris Grove told CNBC. “But the fundamental elements of consumer demand and an array of diverse brands looking to meet that demand are clearly in place.”

That growth will be fueled by sports, which E&K predicts will represent 44% of the long-run volume for prediction markets.

The booming predictions space allows users to wager on events in culture, politics and sports, among other markets. A rise in popularity for platforms like Polymarket and Kalshi has inspired traditional sportsbooks to launch their own predictions platforms.

Comparing prediction trading volume to sportsbooks handle, or amount wagered, is complicated, because in prediction markets both sides of the trade are counted as volume. 

For instance, if someone buys a 40-cent contract, and someone else takes the 60-cent position — that’s a dollar in trading volume. In sports betting, a dollar bet is strictly a dollar in handle.

E&K crafted a formula to translate predictions volume into handle and concluded that mature sports prediction markets could support sportsbook-style handle that’s roughly 60% to 80% of today’s licensed regulated online sports betting market.

Of course, online sports betting is legal only in 31 states; prediction markets have launched in all 50.   

Robinhood this week introduced additional prediction markets features that allow users to trade NFL parlay and prop bets.

“The sportsbooks definitely see the writing on the wall and how this could completely disrupt their business,” CEO Vlad Tenev told CNBC Wednesday.

Robinhood expands prediction market features with NFL combos and player contracts

Fanatics, in partnership with Crypto.com, launched Fanatics Markets at the beginning of December to offer predictions trades. DraftKings and FanDuel are expected to launch their own prediction platforms by the end of the month.

Right now, platforms like Kalshi, Robinhood, Crypto.com, Polymarket and Fanatics are pulling in roughly $10 billion, according to an analysis this week from Citizens. But analysts note, “Prediction markets are in the early innings of exponential scaling as the asset class transitions from speculation to a more mature component of capital markets, with institutions likely coming next.”

Tenev said it more plainly: “We think we’re in the early stages of a prediction market supercycle.”

As the markets mature, the cross-selling to prediction customers is likely to diverge. After all, the way FanDuel coaxes a prediction customer onto its online sportsbook or icasino will look very different from Robinhood working to persuade a predictions trader to try trading equities.

Still, a broader trend is emerging: the convergence of investing and gambling.

“There’s always been some overlap between the two, but we appear to be living in a world where gambling is become more like investing just as investing is pushing further and further in the direction of gambling,” Grove said.

Disclosure: CNBC and Kalshi have a business relationship.



Source

Real estate could be the big winner in the private credit exodus
Business

Real estate could be the big winner in the private credit exodus

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. Barely […]

Read More
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Business

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients, helping them manage their blood sugar levels and lose weight.  The drug lowered hemoglobin A1c — a key measure of blood sugar levels — by an average of 1.7% to 2% across different doses at […]

Read More
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More